Blog

Education · 7 min read

How Long Does It Take to Get a Semaglutide Prescription Through Telehealth?

The real timeline for an online semaglutide prescription — intake, clinician review, pharmacy fulfillment, and shipping — plus what actually slows it down.

Reviewed byPallas Clinical TeamSep 3, 20267 min read

Most patients complete their intake in minutes, hear back from a clinician within 1–2 business days, and have medication shipped within about a week of approval. The three variables that actually move that timeline are your state's video-visit rule, how completely you fill out your intake, and whether your prescription is a compounded preparation or a pre-manufactured brand-name product. Here's the honest, step-by-step breakdown.

The short answer

Intake takes minutes. Clinician review typically takes 1–2 business days in the 43 states (plus most others) that allow fully asynchronous care, or happens right after your video visit in the states that require one. Once you're prescribed, a licensed pharmacy fills the order and it typically ships within 5–7 days of approval — faster in some states, a bit longer if your prescription needs to be compounded per-patient. There's no guaranteed date; a clinician's decision and a pharmacy's fill time are never instant.

The step-by-step timeline

StepWhat happensTypical time
IntakeYou complete a health questionnaire — history, current medications, prior GLP-1 use, your state of residence5–10 minutes
Clinician reviewA US-licensed clinician reviews your intake and decides whether treatment is appropriateTypically 1–2 business days (async states) or immediately after your video visit (sync-required states)
Prescribing decisionIf appropriate, a prescription is written and sent to a licensed pharmacySame day as review
Pharmacy fulfillmentA retail/mail-order pharmacy fills a brand-name order, or a compounding pharmacy prepares a compounded order per-patientSame day to a few days, depending on product
ShippingThe pharmacy ships your medication, typically with trackingCommonly 5–7 days after approval, nationally — check your state page for a tighter local estimate

Nothing in this table is a guarantee. It's the typical path when an intake is complete and a pharmacy has the product in stock — either can add time, covered below.

How long does clinician review actually take?

Review time comes down to one thing: does your state require a live video visit to establish care, or can it happen by secure message?

Pallas care is asynchronous-first. In the large majority of states, your intake goes straight to a US-licensed clinician, who typically responds within 1–2 business days — no appointment to book, no call to schedule. A smaller set of jurisdictions require one live video visit before a clinician can prescribe: Arkansas, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, and West Virginia — plus Washington, D.C. That's seven states plus a federal district, out of fifty states total; everywhere else is async-eligible. In those sync-required jurisdictions, the clinical review effectively happens during the visit itself, so your timeline depends on how quickly a video slot is available rather than a message queue.

Either way, the review itself is a real clinical decision, not a formality — a clinician may ask follow-up questions, request additional information, or determine that a GLP-1 isn't appropriate for you, any of which can add time beyond the typical window.

How long does shipping take once I'm prescribed?

Once a clinician prescribes, a licensed pharmacy has to actually fill the order before anything ships, and how long that takes depends on which product you're prescribed:

  • FDA-approved brand-name medications — Wegovy® and Ozempic® (semaglutide, Novo Nordisk) — are pre-manufactured and typically fill fastest, since the pharmacy is dispensing existing stock rather than preparing anything.
  • Compounded semaglutide is prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, prescribed when a clinician documents a patient-specific clinical rationale. Preparing it per-patient can add a little time compared with pulling a pre-manufactured box off a shelf.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Brand-name prescriptions through Pallas are cash-pay only and are not billed to insurance today; eligibility for either product is always determined by a US-licensed clinician.

Nationally, shipping typically adds about 5–7 days after your prescription is approved, with free shipping and tracking. That figure varies by state and pharmacy — some state-specific pages report a tighter 2–3 or 3–5 business-day window once the pharmacy fills the order, so check your state-by-state GLP-1 directory entry for the closer estimate where one exists.

Ready to start the clock?

Complete a short health questionnaire and a US-licensed clinician will review whether semaglutide is appropriate for you — most states never require a video call.

Start your intake →

What can delay my prescription or shipment?

The typical timeline assumes a complete intake and a pharmacy with the product in stock. A few things reliably add time:

  • An incomplete or inconsistent intake. Missing medication history, an unclear answer, or information that doesn't match your other records can prompt a clinician to follow up before deciding — which pauses the clock until you respond.
  • Identity or photo verification issues. Many telehealth intakes require a photo ID and sometimes a selfie to confirm you are who you say you are; a blurry photo or a name mismatch is a common, easily avoidable delay.
  • Pharmacy backorder. Occasionally a specific dose or form is temporarily out of stock at a given pharmacy. A legitimate provider will tell you if this happens rather than silently missing your expected ship date.
  • A clinician declining or requesting more information. Not every intake results in an immediate prescription — a personal or family history of certain thyroid cancers, current pregnancy, a history of pancreatitis, or other findings can lead a clinician to ask more questions or determine a GLP-1 isn't appropriate right now.

None of these are unusual, and none of them mean something has gone wrong — but they're the realistic reasons an individual timeline can run longer than the typical range above.

Does the timeline differ in states that require a video visit?

Somewhat, but mainly in how you reach the clinical decision rather than the total time. In async states, the "review" step is a message-based queue that typically clears in 1–2 business days. In the eight sync-required jurisdictions — Arkansas, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, West Virginia, and Washington, D.C. — the review happens live during a scheduled video visit, so your timeline depends on how soon a visit slot is available rather than a review queue. Once a prescription is written, pharmacy fulfillment and shipping work the same way regardless of which path got you there.

Frequently asked questions

For most patients, about a week start to finish: intake takes 5–10 minutes, a US-licensed clinician typically reviews it within 1–2 business days (or right after your video visit in a sync-required state), and medication typically ships within 5–7 days of approval. None of this is guaranteed — a clinician's decision and a pharmacy's fill time are never instant.

In the large majority of states, which allow fully asynchronous care, review typically takes 1–2 business days once your intake is complete. In the handful of states that require a live video visit to establish care, the clinical review happens during that visit, so the timeline depends on how soon a visit is available rather than a message queue.

Typically about 5–7 days nationally, with free shipping and tracking, once a licensed pharmacy fills the order. FDA-approved brand-name semaglutide (Wegovy®, Ozempic®) usually fills fastest since it's pre-manufactured; compounded semaglutide can take a little longer because a US-licensed compounding pharmacy prepares it per-patient. Some states have a tighter published estimate — check your state's GLP-1 page for specifics.

The most common causes are an incomplete or inconsistent intake that prompts a clinician follow-up, identity or photo-ID verification issues, a temporary pharmacy backorder on a specific dose, or a clinician requesting more information before deciding. None of these mean something has gone wrong — they're just the realistic reasons an individual timeline can run past the typical range.

The overall timeline is similar — what changes is how you reach the clinical decision. In video-visit states, you're waiting on an available appointment slot rather than a message-based review queue; once a prescription is written, pharmacy fulfillment and shipping work exactly the same way regardless of which path got you there.

No — the clinical review and pharmacy steps take the same amount of time either way. Brand-name semaglutide dispensed through Pallas is cash-pay only and is not billed to insurance today; compounded semaglutide is also cash-pay. Insurance status doesn't change how quickly a clinician reviews your intake or a pharmacy fills your order.

The bottom line

For most patients, a semaglutide telehealth prescription moves from intake to shipped medication in about a week: minutes to complete intake, 1–2 business days for clinician review (or right after your video visit in a handful of states), and typically 5–7 days for pharmacy fulfillment and shipping once you're approved. A complete intake, a clear ID photo, and a pharmacy with your product in stock are what keep you on that timeline — nothing about it is guaranteed, because a real clinician is making a real decision at every step.

See if you qualify in a few minutes

Pallas's intake is asynchronous in most states — complete it by message, and a US-licensed clinician will let you know if semaglutide treatment is appropriate for you.

Start your intake →

Trademarks & disclosures

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a US-licensed clinician determines treatment is appropriate.